30 research outputs found
Differences in effectiveness and use of laparoscopic surgery in locally advanced colon cancer patients
Silvio O. Conte Digestive Disease Research Core Centers—Connecting People, Creating Opportunities, Developing Careers
The Silvio O. Conte Digestive Research Core Center (DDRCC) program is an initiative funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The program is named after long-serving Massachusetts congressman Silvio O. Conte who sponsored legislation to establish the centers that are designed to bring together basic and clinical investigators to enhance research related to digestive and/or liver diseases and their complications
Dielectric and conductivity relaxation in mixtures of glycerol with LiCl
We report a thorough dielectric characterization of the alpha relaxation of
glass forming glycerol with varying additions of LiCl. Nine salt concentrations
from 0.1 - 20 mol% are investigated in a frequency range of 20 Hz - 3 GHz and
analyzed in the dielectric loss and modulus representation. Information on the
dc conductivity, the dielectric relaxation time (from the loss) and the
conductivity relaxation time (from the modulus) is provided. Overall, with
increasing ion concentration, a transition from reorientationally to
translationally dominated behavior is observed and the translational ion
dynamics and the dipolar reorientational dynamics become successively coupled.
This gives rise to the prospect that by adding ions to dipolar glass formers,
dielectric spectroscopy may directly couple to the translational degrees of
freedom determining the glass transition, even in frequency regimes where
usually strong decoupling is observed.Comment: 8 pages, 7 figure
A global research priority agenda to advance public health responses to fatty liver disease
Background & aims
An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community.
Methods
Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy.
Results
The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% ‘agree’), 13 priorities had 90% combined agreement.
Conclusions
Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.
Impact and implications
An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat
APOBEC-1, the catalytic subunit of the apolipoprotein B mRNA editing enzyme, is a mutifunctional cytidine deaminase with RNA binding activity
Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic acid editing in a murine model of congenital hypothyroidism
International audienc